Rasph

HPNow's EIC Accelerator Bet on Making Peroxide On Site, Revisited

October 14, 20262,374 words12 min

Hydrogen peroxide is made in large chemical plants, shipped at 30% to 70% strength and then diluted at the point of use to a few parts per million. HPNow, a spin-out from the Technical University of Denmark, builds machines that skip the chain: they make a dilute solution on site from water, air and electricity. In March 2020 the European Innovation Council selected the company in the EIC Accelerator pilot, and the EU paid €1,786,750 of a €2,552,500 project, PeroxyPro, to take the generator to market, according to CORDIS. Evonik, one of the world's largest peroxide producers and an HPNow shareholder, said at the time that HPNow was one of only 36 companies funded in that round's call against the coronavirus pandemic, out of about 1,400 applicants, according to its press release.

Six years on, HPNow is still trading and still selling its HPGen units, and it raised €14 million in 2023. But its 2025 annual accounts, filed on 2 July 2026 with the Danish Business Authority, report that "during 2025 sales activities were reduced" while development was refocused, that all capitalised development projects were written off, and that the company ended the year with €1,777,259 in the bank after a net loss of €5,684,154.

€1.79MEU grant for PeroxyPro, 2020 to 2022
€14MEquity round, September 2023
19Average staff, 2024 and 2025
€5.68MNet loss in 2025

Company file

Legal entity
HPNow ApS, CVR 37258822
Incorporated
23 November 2015 per its accounts; North Data shows registration on 27 November 2015
Headquarters
Sydmarken 32, Søborg, near Copenhagen; subsidiary HPNow Ltd in Israel
Management
Rasmus Frydendal and Arnau Verdaguer Casadevall (executive board); Fredrik Östbye, chairman
Investors
Evonik Venture Capital, AP Ventures, EIFO, Novo Holdings, MatiTech
Products
HPGen generators (also marketed as GOgen), producing "Peroxide UltraPure"
EIC project
PeroxyPro, March 2020 cut-off, grant only, CORDIS 960753
EIC Fund
Not in the EIC Fund portfolio

Where HPNow Stands in 2026

HPNow is active. It filed its 2025 accounts in July 2026, and the register shows board changes as recently as May 2026, according to North Data, which lists no insolvency or liquidation notice. Its website, now at hpnow.com, markets the generators for agriculture, data centre cooling, industrial water and municipal odour control.

The leadership has changed. Ziv Gottesfeld, named as chief executive in the 2020, 2022 and 2023 announcements cited below and a member of the executive board in every set of accounts from 2016 to 2023, left the register in November 2024, according to North Data. The 2024 and 2025 accounts name Rasmus Frydendal and Arnau Verdaguer Casadevall, both on the management registered at the 2015 founding, as the executive board. Fredrik Östbye became chairman in January 2026. No public announcement of the change or of a new chief executive title could be found.

The clearest signal of the company's direction is in the 2025 accounts. The note on development projects says the work covered "better performance of current units, both efficiency and durability" and "development activities towards larger modular units", and that "as market potential for these projects compared to the carrying value is uncertain, the projects are fully impaired". The write-off came to €1,704,861. The same note says "future sales depend on the ability to enhance the products". In August 2020, a month into the EIC project, HPNow's product page listed four lines: the A-Series for 0.5 to 2 kg of peroxide a day, the I-Series for "larger-scale demanding applications, requiring 5 kg / day and above", an embedded E-Series for appliances such as dishwashers, and an H-Series for disinfectant. The current technology page describes only the A-Series.

The Technology: Peroxide From Air at the Point of Use

Almost all hydrogen peroxide is made by the anthraquinone process in large plants, which the PeroxyPro objective says emit greenhouse gases "equivalent to the emissions of 3M cars" and over 60 million tonnes of toxic waste a year, figures that are the company's own and that could not be checked against an independent source. The concentrated product is hazardous to ship and store.

HPNow reduces oxygen from air at the cathode of a compact electrolytic cell, with a solid polymer membrane in place of a liquid electrolyte and a proprietary oxygen reduction catalyst, according to its technology page. The output is a dilute solution, which trade coverage of its GOgen systems puts at 1% (DataCenter News, Smart Water Magazine), and which the company says is not classified as hazardous. The research roots are at DTU's SURFCAT catalysis section, which lists HPNow as a spin-out; Novo Holdings dates the spin-out to 2015 and describes the machines as roughly the size of a large household freezer (Novo Holdings).

Delivered peroxide

Made centrally, shipped at 30% to 70% strength, stored as a hazardous chemical and diluted on site.

HPNow's generator

Made on site at low concentration from water, air and electricity; output is limited by the size of the unit.

The trade-off is scale. A freezer-sized unit suits greenhouses, livestock water and cooling towers. Municipal and industrial plants that use peroxide in bulk need larger systems, and those are the development projects HPNow wrote off in 2025.

What PeroxyPro Promised, and What CORDIS Shows

The European Commission's list of EIC Accelerator pilot winners for the March and May 2020 cut-offs shows HPNow, Copenhagen, with PeroxyPro as a grant-only award; no other company is listed for the project. CORDIS shows a signature on 30 June 2020 and a project from 1 July 2020 to 30 June 2022. HPNow's Israeli subsidiary, HPNow Ltd of Gan Yoshiya, took part as a linked third party and received €446,250 of the EU contribution. It was HPNow's second EU grant: a €50,000 SME Instrument Phase 1 feasibility study, HPGen, ran in 2016 and aimed the generator at irrigation and livestock.

The objective promised "the world's first and only commercial technology solution for the on-site generation of hydrogen peroxide through direct electrochemical synthesis", to replace the centralised supply chain in water treatment, pulp and paper, textiles, medical and electronics uses. The final report says the project took the product "from TRL 6 to full commercialization in the Water Safety market segment". Its claims are specific, but most are the company's own and were not confirmed by the customers it names.

  1. Commercial on-site generatorDeliveredHPGen sold through Royal Brinkman to growers from 2022, per HortiDaily; still on sale on hpnow.com.
  2. Pilots turned into paying customersCompany-reportedCORDIS report: two pathogen-control pilots converted, three advanced oxidation pilots. Customers unnamed, except a Danish cooling tower in HPNow's own partner content.
  3. Patent and US EPA device statusCompany-reportedReport cites a granted patent and an EPA "pesticide device" determination; the results page lists one deliverable naming EPA, NSF, BPR, CE and UL. No register entry was checked.
  4. Drinking water use in South African minesNot announcedReport said it would "soon" start; no announcement since.
  5. Larger-scale municipal and industrial systemsNot deliveredDevelopment towards "larger modular units" written off in the 2025 accounts; no municipal plant announced.

The record supports a working, sold product. It does not support the larger claim that PeroxyPro would displace centralised production in the industries the objective listed. The project closed on time, but the scale-up beyond small units, which the final report presented as under way, has not been announced, and the 2025 write-off suggests it stalled.

What Came After the Grant

The private money followed. In November 2020 HPNow closed a €5 million round led by AP Ventures with Evonik's venture arm, according to HortiDaily and Evonik, which first invested in 2017. In September 2023 the company announced a €14 million round led by Denmark's export and investment fund EIFO and Novo Holdings, with MatiTech, Evonik Venture Capital and AP Ventures, to scale up "marketing, sales, technical support and production capacity", according to Novo Holdings and VerticalFarmDaily. The accounts confirm it: share premium rose by about €14.1 million in 2023.

The round came just in time. The 2022 accounts, approved in June 2023, carried a going-concern warning: the budget relied on "an expected capital raise to be finalized in 2023", and without it there was "a material uncertainty that may cast significant doubt on the entity's ability to continue as a going concern". Equity had fallen to €678,002.

"During 2025 sales activities were reduced and development activities focused to adapt the product offerings to expected future demands."

HPNow ApS, annual report 2025, note 4, filed with the Danish Business Authority

Commercial traction is hard to measure. HPNow reports a gross loss, not revenue, under Danish small-company rules, and that gross loss was negative in every year from 2019 to 2025, meaning revenue did not cover the cost of goods and other external costs. In 2025 the gross loss was €2,257,528. Partnerships were announced with Royal Brinkman for horticulture in 2022, and with BSH, the maker of Bosch and Siemens dishwashers, according to Evonik in 2020; no product from the BSH partnership has been announced. Named paying customers remain scarce in public sources.

The Money

HPNow lost €17.54 million in the six years from 2020 to 2025, against €19.08 million of share premium paid in by its shareholders since 2015. The annual loss grew from €534,065 in 2019, the year before the grant, to €5,684,154 in 2025, which includes the €1,704,861 impairment. Equity fell from €12.60 million at the end of 2023 to €3.08 million at the end of 2025, and cash from €9.94 million to €1.78 million.

The runway question

At the 2025 burn rate, €1.78 million of cash does not cover another full year. The 2025 accounts, reviewed by PwC, carry no going-concern note, and no new funding round has been announced in 2026. Whether new money has been raised since the year end could not be verified.

The EIC Fund took no stake. PeroxyPro was a grant-only award, and HPNow does not appear among the 323 companies on the EIC Fund's list of invested companies, checked across all pages on 14 October 2026.

Why Europe Should Care

On-site oxidants fit two strands of EU water policy. The revised Urban Wastewater Treatment Directive, given final approval by the Council on 5 November 2024, requires plants serving 150,000 population equivalents or more to add quaternary treatment to remove micropollutants by 2045, with pharmaceutical and cosmetics producers paying at least 80% of the extra cost, according to Recycling Portal. Advanced oxidation, the process HPNow tested with water technology firms during PeroxyPro, is one candidate. The Commission's Water Resilience Strategy of 4 June 2025 calls for tackling pollutants in drinking water and notes that EU researchers and companies hold about 40% of global water technology patents.

There is also a supply-chain argument. The PeroxyPro objective, written in spring 2020, noted that a peroxide shortage was "already felt in the market" during the first COVID-19 wave. Distributed production makes users less dependent on a few chemical plants and on the transport of a hazardous concentrate. That argument holds only if the generators can be built at the scale bulk users need.

What the award promised

The world's first commercial on-site peroxide generator, displacing centralised production across water treatment and industry.

What the record shows

A small generator on sale to growers and cooling towers, €19 million of equity paid in, 19 staff, sales cut back in 2025 and the scale-up written off.

The Verdict

A product, not yet a business

The EIC grant did what it was meant to do at product level: HPNow left PeroxyPro with a generator it could sell and investors willing to put in €14 million more. What it has not shown is that on-site peroxide can be sold at a profit or at the scale that would challenge the chemical plants. Losses grew every year but one, the larger units were written off, and the company enters 2026 with less than a year of cash at its 2025 burn rate.

HPNow has not been asked for comment for this article. It is based entirely on public records, company statements and EU project data, linked throughout.

Industry

Materials and chemicalsSpecialty chemicals

Focus
  • Performance chemicals
Technologies
  • Electrochemistry
Keywords
  • Hydrogen peroxide
  • Water treatment
  • Irrigation
  • Data centre cooling

Start with the EIC Accelerator

Expert review for Step 1 and Step 2, suitability assessment and grant screening.

Eureka Network

Eureka Network offers multiple international collaborative R&D programs including Network Projects, Clusters, Eurostars, Globalstars, and Innowwide, with funding ranging from €50K to €6.75M per project depending on the specific program. The network focuses on market-driven innovation and deep-tech development across diverse technology sectors including ICT/Digital, Industrial/Manufacturing, Bio/Medical Technologies, Energy/Environment, Quantum, AI, and Circular Economy. Applicants include SMEs, large enterprises, research organizations, universities, and startups, with Eurostars specifically targeting R&D-performing SMEs.

EIC Transition

EIC Transition provides up to €2.5 million in funding to bridge the 'valley of death' between laboratory research and market deployment, focusing on technology maturation and validation. The program supports single legal entities or small consortia of 2-5 partners including SMEs, start-ups, spin-offs, and research organizations. Technology areas include Health/Medical Technologies, Green/Environmental Innovation, Digital/Microelectronics, Quantum Technologies, and AI/Robotics.

EIC STEP Scale-Up

EIC STEP Scale-Up offers substantial equity investments of €10-30 million for established deep-tech companies ready for hyper-growth and large-scale expansion. The program targets SMEs or small mid-caps with up to 499 employees who have secured pre-commitment from qualified investors. Focus areas include Digital & Deep Tech (Semiconductors, AI, Quantum), Clean Technologies for Net-Zero goals, and Biotechnologies.

EIC Pre-Accelerator

EIC Pre-Accelerator is a pilot program providing €300,000-€500,000 in funding for early-stage deep-tech development and preparation for the EIC Accelerator program. The initiative is exclusively available to single SMEs or small mid-caps from 'Widening countries' to support regional innovation development. The program covers deep-tech innovations across physical, biological, and digital domains.

EIC Advanced Innovation Challenges

EIC Advanced Innovation Challenges is a new pilot program offering €300,000 (Stage 1) and up to €2.5 million (Stage 2) for breakthrough deep-tech solutions through ARPA-style staged funding with demand-side integration. The program targets single entities or small consortia (2-3 partners) including SMEs, start-ups, and research organizations. Focus areas include Physical AI for autonomous robotics and New Approach Methodologies (NAMs) for animal-free biomedical testing, requiring TRL 4 entry with end-user commitment.

EIC Pathfinder

EIC Pathfinder offers up to €3 million for Open calls and up to €4 million for Challenge-based calls to support early-stage research and development with proof-of-principle validation. The program requires research consortia with a minimum of 3 partners from 3 different countries, including universities, research organizations, and SMEs. Technology focus areas include Health/Medical, Quantum Technologies, AI, Environmental/Energy, and Advanced Materials.

EIC Accelerator

EIC Accelerator provides flexible funding options including blended finance (€2.5M grant + €0.5M-€10M equity), grant-only (up to €2.5M), or equity-only arrangements for scale-up and market deployment of breakthrough innovations. The program targets SMEs, start-ups, and small mid-caps with up to 499 employees, with MedTech/Healthcare representing 35% of funded projects. Other technology areas include Biopharma, Energy, AI, Quantum, Aerospace, Advanced Materials, and Semiconductors.

Innovation Partnership

Innovation Partnership facilitates collaborative innovation between public and private sectors with typical funding of €1-5 million per project. The program supports cross-sectoral strategic technologies through public-private partnerships and consortia. Projects focus on addressing societal challenges through collaborative innovation approaches.

Innovation Fund

The EU Innovation Fund provides substantial funding of €7.5 million to €300 million for large-scale demonstration of innovative low-carbon technologies. The program targets clean energy, carbon capture, renewable energy, and energy storage technologies to accelerate the transition to a low-carbon economy. Applicants include large companies, consortia, and public entities capable of implementing large-scale demonstration projects.

Innovate UK

Innovate UK offers various programs with funding ranging from £25K to £10M depending on the specific initiative, supporting business-led innovation, collaborative R&D, and knowledge transfer. The organization funds projects across all sectors with particular focus on emerging technologies and supports UK-based businesses, research organizations, and universities. Programs are designed to drive economic growth through innovation and technology commercialization.

Industrial Partnership

Industrial Partnership provides €2-10 million in funding for industrial research and innovation partnerships focusing on manufacturing, industrial technologies, and digital transformation. The program supports industrial consortia and research organizations in developing collaborative solutions for industrial challenges. Projects aim to strengthen European industrial competitiveness through strategic partnerships.

Eurostars

Eurostars is a joint EU-Eureka program offering €50K-€500K for international R&D collaboration specifically led by SMEs. The program takes a bottom-up approach, accepting projects from all technology fields without predefined thematic restrictions. R&D-performing SMEs must lead the consortium and demonstrate significant R&D activities.

LIFE Programme

The LIFE Programme provides €1-10 million in funding for environmental protection, climate action, and nature conservation projects across the European Union. The program supports environmental technologies, climate adaptation strategies, and biodiversity conservation initiatives. Applicants include public authorities, private companies, NGOs, and research institutions working on environmental and climate challenges.

Neotec

Neotec is a Spanish program offering €250K-€1M in funding for technology-based business creation and development, supporting the growth of innovative Spanish SMEs and start-ups. The program covers all technology sectors and aims to strengthen Spain's technology ecosystem. Funding is specifically targeted at Spanish technology-based SMEs and start-ups to enhance their competitiveness and market presence.

Thematic Priorities

EU Thematic Priorities encompass various programs aligned with EU strategic priorities including green transition, digital transformation, health, and security initiatives. Funding amounts vary based on the specific program and call requirements, with projects designed to address key European challenges. Applicant eligibility varies by specific program and call, with different requirements for different thematic areas.
EIC AcceleratorBeneficiary Deep Dive#HPNow#PeroxyPro#hydrogen peroxide#electrochemistry#water treatment#power-to-X#Denmark
Loading